1984Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)Requires access

Serum bactericidal activity of ampicillin and mezlocillin with and without sulbactam

P Van der Auwera, Jean Klášterský

Open publisher page 8 citations

Abstract

Two groups of five volunteers received the following regimens on three consecutive days: group 1: ampicilllin 3 g, sulbactam 1 g, ampicillin 3 g + sulbactam 1 g; group 2: mezlocillin 3 g, sulbactam 1 g, mezlocillin 3 g + sulbactam 1 g. The drugs were given intravenously. Serum bactericidal activity (SBA) was measured against 24 strains producing various beta-lactamases: 3 Staphyloccus aureus, 3 Escherichia coli, 4 Klebsiella pneumoniae, 2 indole-positive Proteus, 4 Pseudomonas aeruginosa, 2 Bacteroides fragilis and 3 Bacteroides thetaiotaomicron. One strain of penicillin-sensitive Staphylococcus aureus was also tested. Sulbactam significantly increased the SBA of ampicillin against S. aureus, B. fragilis and B. thetaiotaomicron. Sulbactam increased the SBA of mezlocillin against S. aureus only.

About this research paper

What this paper is about

Two groups of five volunteers received the following regimens on three consecutive days: group 1: ampicilllin 3 g, sulbactam 1 g, ampicillin 3 g + sulbactam 1 g; group 2: mezlocillin 3 g, sulbactam 1 g, mezlocillin 3 g + sulbactam 1 g. The drugs were given intravenously. Serum bactericidal activity (SBA) was measured against 24 strains producing various beta-lactamases: 3 Staphyloccus aureus, 3 Escherichia coli, 4 Klebsiella pneumoniae, 2 indole-positive Proteus, 4 Pseudomonas aeruginosa, 2 Bacteroides fragilis and 3 Bacteroides thetaiotaomicron. One strain of penicillin-sensitive Staphylococcus aureus was also tested. Sulbactam significantly increased the SBA of ampicillin against S. aureus, B. fragilis and B. thetaiotaomicron. Sulbactam increased the SBA of mezlocillin against S. aureus only.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Two groups of five volunteers received the following regimens on three consecutive days: group 1: ampicilllin 3 g, sulbactam 1 g, ampicillin 3 g + sulbactam 1 g; group 2: mezlocillin 3 g, sulbactam 1 g, mezlocillin 3 g + sulbactam 1 g. The drugs were given intravenously. Serum bactericidal activity (SBA) was measured against 24 strains producing various beta-lactamases: 3 Staphyloccus aureus, 3 Escherichia coli, 4 Klebsiella pneumoniae, 2 indole-positive Proteus, 4 Pseudomonas aeruginosa, 2 Bacteroides fragilis and 3 Bacteroides thetaiotaomicron. One strain of penicillin-sensitive Staphylococcus aureus was also tested. Sulbactam significantly increased the SBA of ampicillin against S. aureus, B. fragilis and B. thetaiotaomicron. Sulbactam increased the SBA of mezlocillin against S. aureus only.

Key concepts: Sulbactam, Mezlocillin, Bacteroides fragilis, Microbiology, Staphylococcus aureus, Ampicillin, Klebsiella pneumoniae, Proteus mirabilis

Related papers

Back to paper searchBrowse research topicsOriginal source
Serum bactericidal activity of ampicillin and mezlocillin with and without sulbactam — Research Paper | ScholarLens